Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis.

Saved in:
Bibliographic Details
Title: Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis.
Authors: Afferi L; Harvard T. H. Chan School of Public Health, Boston, MA, USA. luca.afferi@gmail.com.; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. luca.afferi@gmail.com.; Department of Urology, Fundació Puigvert, Barcelona, Spain. luca.afferi@gmail.com., Jahn B; Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Hall in Tirol, Austria., Kelkar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Dijk SW; Department of Radiology and Nuclear Medicine, Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands., Feldman ZM; Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA, USA., Ward ZJ; Center for Health Decision Science, Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Moschini M; Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Cathomas R; Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland., Bellmunt J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Parc de Salut Mar, Hospital del Mar Medical Research Institute, Barcelona, Spain., Gallioli A; Department of Urology, Fundació Puigvert, Barcelona, Spain., Breda A; Department of Urology, Fundació Puigvert, Barcelona, Spain., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Mattei A; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Chang SL; Harvard Medical School, Boston, MA, 02215, USA.; Division of Urologic Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA., Siebert U; Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Hall in Tirol, Austria.; Center for Health Decision Science, Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Program on Cardiovascular Research, Institute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Source: World journal of urology [World J Urol] 2025 Mar 30; Vol. 43 (1), pp. 197. Date of Electronic Publication: 2025 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1433-8726
DOI:10.1007/s00345-025-05584-7